Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Commissural and Coronary Alignment and TAVI
Author(s): Clara Fernandez-Cordón , Ignacio Amat-Santos Added: 1 day ago

Intervention

Demographic
30th Annual Meeting of the ISCP
Author(s): Daniel García Iglesias , Fernando López Iglesias , Rodrigo Ariel di Massa , et al Added: 2 months ago

Imaging & Diagnostics

Prevention & Chronic Conditions
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
Added: 2 months ago Source:  Arrhythmia and Electrophysiology Review
Conduction system pacing has emerged as a potential alternative to conventional biventricular pacing (BiVP) for delivering cardiac resynchronization therapy (CRT). The recent LEFT-BUNDLE-CRT trial aimed to determine if left-bundle branch area pacing (LBBAP) is non-inferior to BiVP in patients with guideline-based indications for CRT and left-bundle branch block (LBBB).¹MethodologyThe LEFT-BUNDLE… View more

Electrophysiology & Arrhythmia
Intracardiac Thrombi in Behçet’s Disease
Author(s): Anas M Barabrah , Anas R Tuqan , Sara M Darawish , et al Added: 23 hours ago

Imaging & Diagnostics

Intervention
Cardiac Diseases in Sudan
Author(s): Eldisugi Hassan Mohammed Humida , Hussain Gadelkarim Ahmed Added: 1 week ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
AHA 25: MAPLE-HCM Responder Analysis
Author(s): Andrew Wang Added: 7 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive… View more

Heart Failure
Research Area(s) / Expertise:
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC is the President-Elect of the American Society for Preventive Cardiology. She was a Professor of Medicine and the inaugural Chief of Cardiology at the University of Arizona. Previously, she held the Sarah Ross Soter Chair in Women’s Cardiovascular Health and was the Section Director for Women’s Cardiovascular Health and Preventive Cardiology at The… View more
30th Annual Meeting of the ISCP
Author(s): Raúl Ludeña , Raúl Ptaszynski Lanza , Beatriz Nieves Ureña , et al Added: 2 months ago

Prevention & Chronic Conditions
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions
Oral Orforglipron Superior to Semaglutide for T2D Control
Added: 3 months ago Source:  Radcliffe CVRM
A new study has found that the novel oral GLP-1 receptor agonist, orforglipron, demonstrated superior glycaemic control compared to oral semaglutide in adults with type 2 diabetes (T2D). The findings come from the ACHIEVE-3 trial, a phase 3 study published in The Lancet.¹Mechanism of ActionOrforglipron is a non-peptide glucagon-like peptide-1 (GLP-1) receptor agonist designed for once-daily oral… View more

Cardiovascular Kidney Metabolic